MedTrace Logo

Intra-articular Injections for Knee Osteoarthritis: A Single Blinded Prospective Randomized Trial

NCT02995083 · Status: WITHDRAWN · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL

Last updated 2017-12-18

No results posted yet for this study

Summary

To investigate the clinical benefit of intra-articular injections of saline in patients with symptomatic osteoarthritis of the knee and compare the clinical response of saline to the current standard treatment with corticosteroids and an air injection placebo.

Conditions

  • Symptomatic Osteoarthritis of the Knee

Interventions

DRUG

40 mg Depo-Medrol in 1 ml, 9 ml of 1% lidocaine

Patients will receive an ultrasound guided intra-articular injection of 40 mg Depo-Medrol in 1 ml, 9 ml of 1% lidocaine

DRUG

Normal Saline 10 ml

Patients will receive an ultrasound guided intra-articular injection of Normal Saline 10 ml

DRUG

Air 10 ml

Patients will receive an ultrasound guided intra-articular injection of Air 10 ml

Sponsors & Collaborators

  • Rush University Medical Center

    lead OTHER

Principal Investigators

  • Nikhil N Verma, MD · Midwest Orthopaedics at Rush University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-06-30
Primary Completion
2018-01-31
Completion
2018-01-31
FDA Drug
Yes

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02995083 on ClinicalTrials.gov